Warning: The NCBI web site requires JavaScript to function. more...
An official website of the United States government
The .gov means it's official. Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you're on a federal government site.
The site is secure. The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.
SPRR3 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
GEO DataSets Gene Profile neighbors Chromosome neighbors Homologene neighbors
CCL26 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
FOSL2 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
GEO DataSets Profile neighbors
ZNF101 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
ARL8A - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
FABP1 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
TMED7-TICAM2 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
GEO DataSets Gene Profile neighbors Chromosome neighbors
LOC101927038 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
PWWP2B - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
CMTM4 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
GOLGA7 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
MOB3C - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
SKIL - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
MIPOL1 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
KLK7 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
ZFAND3 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
KLF3 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
Filters: Manage Filters
Your browsing activity is empty.
Activity recording is turned off.
Turn recording back on